Medication info
Xone Tablet 10/160 mg

Xone Tablet 10/160 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Adipate›13.57mg / 1 tablet
Manufacturer / importer
HK Inno.N Co., Ltd.
Appearance
Bright yellow oval film-coated tablet
Packaging
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle, 90 tablets/bottle
Approval status
Active

MFDS item code 201308287 · Approved 2013.07.18 · Insurance code 640006570

Summary

Main use
Treatment of essential hypertension inadequately controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medicine may be considered as follows. ㆍ5/80mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or valsartan 80mg as monotherapy. ㆍ5/160mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or valsartan 160mg as monotherapy. ㆍ10/160mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg or valsartan 160mg as monotherapy, or with 5/160mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer this medicine to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
Use of this medicine is not recommended in pediatric patients under 18 years of age because safety and efficacy have not been established.

Ingredients

Manufacturer
HK Inno.N Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with monotherapy

  • Essential Hypertension
View approved original text

This medicine is used to effectively manage blood pressure in patients with essential hypertension who are inadequately controlled with monotherapy using amlodipine or valsartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medicine may be considered as follows. ㆍ5/80mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or valsartan 80mg as monotherapy. ㆍ5/160mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or valsartan 160mg as monotherapy. ㆍ10/160mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg or valsartan 160mg as monotherapy, or with 5/160mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer this medicine to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

Use of this medicine is not recommended in pediatric patients under 18 years of age because safety and efficacy have not been established.

Precautions

This medication may cause severe harm to the fetus and newborn if administered to pregnant women in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with an allergy to any of the ingredients in this medication or with severe renal and hepatic impairment should not use it. Patients with sodium or fluid depletion in the body may experience hypotension, so their condition should be carefully checked prior to administration, and close monitoring is required at the start of treatment. Patients with high potassium levels or those taking medications that may increase potassium levels should use this drug cautiously with frequent monitoring of potassium levels. Patients with renal artery stenosis or recent kidney transplants also require monitoring of kidney function when using this medication. If symptoms of angioedema occur, stop taking the medication immediately and do not re-administer it, and use it cautiously in patients with heart failure or myocardial infarction. In patients with acute myocardial infarction, caution is warranted at the initiation of treatment or dose escalation, as angina or myocardial infarction symptoms may worsen. Like other vasodilators, special caution is required when administering this drug to patients with aortic stenosis or obstructive hypertrophic cardiomyopathy. Combining this medication with RAAS-affecting drugs such as angiotensin-converting enzyme inhibitors or aliskiren is not recommended. While taking this medication, side effects such as headache, dizziness, palpitations, swelling, fatigue, rash, and dyspepsia may occur, so if any unusual symptoms arise, consult a physician. Dizziness or fatigue may occur when driving or operating machinery, so caution is advised. This medication may interact with certain other medications, so if you are taking other drugs, it is essential to inform your doctor or pharmacist. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are also advised to avoid this medication. It is not recommended for children under 18 years, as safety and efficacy have not been established. Elderly patients can be given the same dosage as adults, but caution may be needed depending on their condition. In case of overdose, severe hypotension or heart function abnormalities may occur, so strict adherence to the prescribed dosage is essential, and if any unusual symptoms occur, notify healthcare personnel immediately.

Side effects

  • Pharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • headache
  • dizziness
  • drowsiness
  • orthostatic dizziness
  • paresthesia
Show 107 more
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • oropharyngeal and laryngeal pain
  • diarrhea
  • nausea
  • abdominal pain
  • constipation
  • dry mouth
  • rash
  • erythema
  • hyperhidrosis
  • rash
  • itching
  • joint swelling
  • low back pain
  • arthritis
  • muscle cramps
  • lethargy
  • polyuria
  • nocturia
  • erectile dysfunction
  • edema
  • anasarca
  • facial edema
  • peripheral edema
  • fatigue
  • flushing
  • weakness
  • facial flushing
  • decrease in hemoglobin
  • decrease in hematocrit
  • neutropenia
  • thrombocytopenia
  • serum sickness
  • increased serum potassium
  • vasculitis
  • elevated liver function tests
  • angioedema
  • myalgia
  • renal failure
  • kidney damage
  • increased serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory tract infection
  • viral infection
  • diplopia
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • sensory impairment
  • taste disturbance
  • peripheral neuropathy
  • hypertonia
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • shortness of breath
  • rhinitis
  • vomiting
  • dyspepsia
  • pancreatitis
  • gastritis
  • gingival hyperplasia
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • phototoxic reaction
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • myalgia
  • urinary disorders
  • nocturnal enuresis
  • gynecomastia
  • pain
  • malaise
  • chest pain
  • weight loss
  • weight gain
  • increased liver enzymes
  • leukopenia
  • thrombocytopenia
  • confusion
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • phototoxic reaction
  • toxic epidermal necrolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is best to keep the storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3), 30 tablets/bottle, 90 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.